trending Market Intelligence /marketintelligence/en/news-insights/trending/Xdv_ARHbBtpLHvSKNhAgSQ2 content esgSubNav
In This List

Zosano Pharma receives Nasdaq noncompliance notice

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Zosano Pharma receives Nasdaq noncompliance notice

Zosano Pharma Corp. received a notice from the Nasdaq Stock Market LLC for failing to meet the $1 minimum bid price listing requirement.

The company has 180 days, or until May 29, 2018, to regain compliance.

To regain compliance, the closing bid price of the company's common stock must meet or exceed $1 per share for a minimum of 10 consecutive business days during the 180-day period.